Literature DB >> 1719014

Characterization of two monoclonal antibodies to Epstein-Barr virus diffuse early antigen which react to two different epitopes and have different biological function.

C H Tsai1, M V Williams, R Glaser.   

Abstract

Five monoclonal antibodies (mAbs) were identified using immunofluorescence that were specific for the Epstein-Barr virus (EBV) encoded 52/50 kDa early antigen (EA-D) protein complex. Evidence to suggest that these mAbs react with the same 52/50 kDa EA-D protein was obtained by Western blotting, immunoprecipitation and ELISA. Two of the mAbs, 90E2 and 214A9, neutralized EBV DNA polymerase activity. The 214A9 mAb also inhibited the activity of bacteriophage T4 DNA polymerase while the 90E2 mAb did not. These data suggest that the 90E2 and 214A9 mAbs recognize two different epitopes on the 52/50 kDa EA-D protein. The high frequency of recovery of hybridomas producing anti 52/50 kDa EA-D mAbs suggest that this protein may have an important role in EBV pathogenesis/replication.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719014     DOI: 10.1016/0166-0934(91)90006-l

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  10 in total

1.  Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes.

Authors:  Y Chang; C H Tung; Y T Huang; J Lu; J Y Chen; C H Tsai
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Induction of Epstein-Barr virus latent membrane protein 1 by a lytic transactivator Rta.

Authors:  Yao Chang; Heng-Huan Lee; Shih-Shin Chang; Tsuey-Ying Hsu; Pei-Wen Wang; Yu-Sun Chang; Kenzo Takada; Ching-Hwa Tsai
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

3.  Characterization of sublines of Epstein-Barr virus producing HR-1 cells and its implication in virus propagation in culture.

Authors:  G Q Yao; C H Tsai; Y C Cheng
Journal:  Virus Genes       Date:  1995-02       Impact factor: 2.332

4.  Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.

Authors:  Yen-Ju Chen; Yu-Lian Chen; Yao Chang; Chung-Chun Wu; Ying-Chieh Ko; Sai Wah Tsao; Jen-Yang Chen; Su-Fang Lin
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

5.  Characterization of the uracil-DNA glycosylase activity of Epstein-Barr virus BKRF3 and its role in lytic viral DNA replication.

Authors:  Chih-Chung Lu; Ho-Ting Huang; Jiin-Tarng Wang; Geir Slupphaug; Tsai-Kun Li; Meng-Chuan Wu; Yi-Chun Chen; Chung-Pei Lee; Mei-Ru Chen
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

6.  Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle.

Authors:  Shih-Hsin Chiu; Meng-Chuan Wu; Chung-Chun Wu; Yu-Ching Chen; Su-Fang Lin; John T-A Hsu; Chung-Shi Yang; Ching-Hwa Tsai; Kenzo Takada; Mei-Ru Chen; Jen-Yang Chen
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

7.  Epstein-Barr virus BGLF4 kinase induces disassembly of the nuclear lamina to facilitate virion production.

Authors:  Chung-Pei Lee; Yu-Hao Huang; Su-Fang Lin; Yao Chang; Yu-Hsin Chang; Kenzo Takada; Mei-Ru Chen
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

8.  EBV reactivation as a target of luteolin to repress NPC tumorigenesis.

Authors:  Chung-Chun Wu; Chih-Yeu Fang; Hui-Yu Hsu; Hsin-Ying Chuang; Yu-Jhen Cheng; Yen-Ju Chen; Sheng-Ping Chou; Sheng-Yen Huang; Su-Fang Lin; Yao Chang; Ching-Hwa Tsai; Jen-Yang Chen
Journal:  Oncotarget       Date:  2016-04-05

9.  Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin.

Authors:  Chung-Chun Wu; Chih-Yeu Fang; Yu-Jhen Cheng; Hui-Yu Hsu; Sheng-Ping Chou; Sheng-Yen Huang; Ching-Hwa Tsai; Jen-Yang Chen
Journal:  J Biomed Sci       Date:  2017-01-05       Impact factor: 8.410

10.  Emodin Inhibits EBV Reactivation and Represses NPC Tumorigenesis.

Authors:  Chung-Chun Wu; Mei-Shu Chen; Yu-Jhen Cheng; Ying-Chieh Ko; Su-Fang Lin; Ing-Ming Chiu; Jen-Yang Chen
Journal:  Cancers (Basel)       Date:  2019-11-15       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.